pI: 4.8872 |
Length (AA): 440 |
MW (Da): 50401 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
26 | 201 | 4r6f (A) | 43 | 218 | 29.00 | 0.000021 | 1 | 0.6912 | -0.28 |
46 | 150 | 4fho (A) | 143 | 242 | 31.00 | 0.015 | 1 | 0.713836 | -1.22 |
68 | 145 | 3g06 (A) | 243 | 339 | 42.00 | 0.053 | 0.99 | 0.301473 | 0.88 |
69 | 127 | 4b8c (D) | 359 | 418 | 36.00 | 0.56 | 1 | 0.615291 | -0.38 |
329 | 439 | 5j0l (D) | 3 | 119 | 15.00 | 0.67 | 0.15 | 0.485173 | -1.31 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic. | Siegel TN |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128896)
Species | Accession | Gene Product |
---|---|---|
Drosophila melanogaster | Dmel_CG31623 | defective transmitter release |
Echinococcus granulosus | EgrG_000177200 | leucine rich repeat containing protein 50 |
Echinococcus multilocularis | EmuJ_000177200 | leucine rich repeat containing protein 50 |
Giardia lamblia | GL50803_11885 | Phosphatase 1 regulatory subunit, putative |
Homo sapiens | ENSG00000154099 | dynein, axonemal, assembly factor 1 |
Leishmania braziliensis | LbrM.35.5130 | hypothetical protein, conserved |
Leishmania braziliensis | LbrM.32.0820 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_365110.1 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_320770.1 | Outer row dynein-assembly protein 7 |
Leishmania infantum | LinJ.36.5110 | hypothetical protein, conserved |
Leishmania infantum | LinJ.32.0770 | hypothetical protein, conserved |
Leishmania major | LmjF.32.0730 | hypothetical protein, conserved |
Leishmania major | LmjF.36.4890 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.4890 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.31.0730 | hypothetical protein, conserved |
Mus musculus | ENSMUSG00000031831 | dynein, axonemal assembly factor 1 |
Neospora caninum | NCLIV_065070 | leucine rich repeat protein, putative |
Neospora caninum | NCLIV_033520 | leucine rich repeat protein, putative |
Plasmodium berghei | PBANKA_1360600 | leucine-rich repeat protein |
Plasmodium falciparum | PF3D7_1347800 | leucine-rich repeat protein |
Plasmodium knowlesi | PKNH_1253100 | leucine-rich repeat protein |
Plasmodium vivax | PVX_083285 | leucine-rich repeat protein |
Plasmodium yoelii | PY06074 | hypothetical protein |
Schmidtea mediterranea | mk4.004508.01 | Dynein assembly factor 1, axonemal homolog |
Trypanosoma brucei gambiense | Tbg972.11.12370 | hypothetical protein, conserved |
Trypanosoma brucei gambiense | Tbg972.11.15610 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.11.11040 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.11.13980 | Outer row dynein-assembly protein 7 |
Trypanosoma congolense | TcIL3000.11.14340 | Outer row dynein-assembly protein 7 |
Trypanosoma congolense | TcIL3000.11.11760 | Leucine Rich repeats (2 copies), putative |
Trypanosoma cruzi | TcCLB.507841.30 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.511727.310 | Outer row dynein-assembly protein 7 |
Trypanosoma cruzi | TcCLB.508269.70 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_047300 | protein phosphatases pp1 regulatory subunit, putative |
Trichomonas vaginalis | TVAG_376770 | protein phosphatases pp1 regulatory subunit, putative |
Trichomonas vaginalis | TVAG_484580 | protein phosphatases pp1 regulatory subunit, putative |
Trichomonas vaginalis | TVAG_179810 | protein phosphatases pp1 regulatory subunit, putative |
Trichomonas vaginalis | TVAG_216780 | protein phosphatases pp1 regulatory subunit, putative |
Trichomonas vaginalis | TVAG_299230 | protein phosphatases pp1 regulatory subunit, putative |
Trichomonas vaginalis | TVAG_035130 | protein phosphatases pp1 regulatory subunit, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.2830 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.2830 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.2830 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb11.01.2830 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb11.01.5550 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.5550 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.5550 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.5550 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.